88
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Risk Factor Analysis for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

, &
Pages 9923-9929 | Published online: 16 Dec 2021

References

  • Walgama E, Sacks WL, Ho AS. Papillary thyroid microcarcinoma: optimal management versus overtreatment. Curr Opin Oncol. 2020;32(1):1–6. doi:10.1097/CCO.0000000000000595
  • Liu Z, Wang L, Yi P, Wang CY, Huang T. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol. 2014;7(3):932–937.
  • Haber RS. Role of ultrasonography in the diagnosis and management of thyroid cancer. Endocr Pract. 2000;6(5):396–400. doi:10.4158/ep.6.5.396
  • Li F, Zhang J, Wang Y, Liu L. Clinical value of elasticity imaging and contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma. Oncol Lett. 2015;10(3):1371–1377. doi:10.3892/ol.2015.3387
  • Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144(6):980–988. doi:10.1016/j.surg.2008.08.035
  • Chow SM, Law SCK, Chan JKC, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid - prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98(1):31–40. doi:10.1002/cncr.11442
  • Yin X, Liu C, Guo Y, et al. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients. World J Surg Oncol. 2017;15(1). doi:10.1186/s12957-017-1202-8
  • Wada N, Duh Q-Y, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas. Ann Surg. 2003;237(3):399–407. doi:10.1097/01.sla.0000055273.58908.19
  • Zheng X, Peng C, Gao M, et al. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1587 patients. Cancer Biol Med. 2019;16(1):121–130. doi:10.20892/j.issn.2095-3941.2018.0125
  • Zhao Q, Ming J, Liu C, et al. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013;20(3):746–752. doi:10.1245/s10434-012-2654-2
  • Siddiqui S, White MG, Antic T, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid. 2016;26(6):807–815. doi:10.1089/thy.2015.0429
  • Xue S, Wang P, Liu J, Li R, Zhang L, Chen G. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: a retrospective study in China. Asian J Surg. 2016;39(3):131–136. doi:10.1016/j.asjsur.2015.03.015
  • So YK, Seo MY, Son YI. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. Surgery. 2012;151(2):192–198. doi:10.1016/j.surg.2011.02.004
  • Babli S, Payne RJ, Mitmaker E, Rivera J. Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer. Eur Thyroid J. 2018;7(2):95–101. doi:10.1159/000486367
  • Aydoğan Bİ, Mutlu ABB, Yüksel S, et al. The association of histologically proven chronic lymphocytic thyroiditis with clinicopathological features, lymph node metastasis, and recurrence rates of differentiated thyroid cancer. Endocr Pathol. 2021;32(2):280–287. doi:10.1007/s12022-020-09653-y
  • Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008;22(6):901–911. doi:10.1016/j.beem.2008.09.019
  • Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13°MHz) ultrasound examination. Eur J Clin Invest. 2009;39(8):699–706. doi:10.1111/j.1365-2362.2009.02162.x
  • Lim YC, Choi EC, Yoon YH, Kim EH, Koo BS. Central lymph node metastases in unilateral papillary thyroid microcarcinoma. Br J Surg. 2009;96(3):253–257. doi:10.1002/bjs.6484
  • Calò PG, Pisano G, Medas F, et al. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment? World J Surg Oncol. 2014;12(1):152. doi:10.1186/1477-7819-12-152
  • Shan CX, Zhang W, Jiang DZ, Zheng XM, Liu S, Qiu M. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope. 2012;122(4):797–804. doi:10.1002/lary.22162
  • Docimo G, Tolone S, Conzo G, et al. A gelatin-thrombin matrix topical hemostatic agent (Floseal) in combination with harmonic scalpel is effective in patients undergoing total thyroidectomy: a prospective, multicenter, single-blind, randomized controlled trial. Surg Innov. 2016;23(1):23–29. doi:10.1177/1553350615596638
  • Conzo G, Calò PG, Gambardella C, et al. Controversies in the surgical management of thyroid follicular neoplasms. Retrospective analysis of 721 patients. Int J Surg. 2014;12(S1):S29–S34. doi:10.1016/j.ijsu.2014.05.013
  • Liu LS, Liang J, Li JH, et al. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis. Eur Arch Otorhinolaryngol. 2017;274(3):1327–1338. doi:10.1007/s00405-016-4302-0
  • Nixon IJ, Kuk D, Wreesmann V, et al. Defining a valid age cutoff in staging of well-differentiated thyroid cancer. Ann Surg Oncol. 2016;23(2):410–415. doi:10.1245/s10434-015-4762-2
  • Johannessen JV, Sobrinho-Simoes M. The origin and significance of thyroid psammoma bodies. Lab Investig. 1980;43(3):287–296.
  • Oh EM, Chung YS, Song WJ, Lee YD. The pattern and significance of the calcifications of papillary thyroid microcarcinoma presented in preoperative neck ultrasonography. Ann Surg Treat Res. 2014;86(3):115–121. doi:10.4174/astr.2014.86.3.115
  • Gui CY, Qiu SL, Peng ZH, Wang M. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study. J Endocrinol Invest. 2018;41(4):403–409. doi:10.1007/s40618-017-0759-y